18,618 followers
The adverse impact of a gain in chromosome 1q on the prognosis of multiple myeloma treated with bortezomib-based regimens: A retrospective single-center study in China https://t.co/XeIWVho3dL https://t.co/CfvLecVMMI
The adverse impact of a gain in chromosome 1q on the prognosis of multiple myeloma treated with bortezomib-based regimens: A retrospective single-center study in China https://t.co/XeIWVho3dL https://t.co/CfvLecVMMI
New research: The adverse impact of a gain in chromosome 1q on the prognosis of multiple myeloma treated with bortezomib-based regimens: A retrospective single-center study in China: Background Multiple myeloma is genetically heterogeneous,… https://t.co/